Nexgen Therapeutics is excited to join ACG 2025 in Phoenix! We look forward to connecting with the GI community and presenting our flagship iLivTouch®—a state-of-the-art VCTE system with FDA-cleared B-mode liver imaging. Designed for accuracy and reliability across MASH/MASLD patients, iLivTouch empowers providers to deliver better liver care and improve patient outcomes.